This review summarizes the current research findings by which GLP-1RAs treatment of diabetic osteoporosis, postmenopausal osteoporosis and glucocorticoid-induced osteoporosis and describes possible mechanisms, such as GLP-1R/MAPK signaling pathway, GLP-1R/PI3K/AKT signaling pathway and Wnt/-catenin pathway, that are associated with GLP-1RAs and osteoporosis
Key Capabilities: AI photo analysis: Snap your meal and let the app calculate macros
Across anti-obesity medications broadly, gastrointestinal disorders represent the most frequent adverse events (29.10%), followed by central/peripheral nervous system disorders (19.17%) and psychiatric manifestations (16.87%)
Manufactured using validated peptidesynthesis and complexation processes to ensure high purity and lottolot consistency
La A, Nguyen T, Tran K, Sauble E, Tu D, Gonzalez A, et al